BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26146615)

  • 1. Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future Implications.
    Chang J; Schomer D; Dragovich T
    Biomed Res Int; 2015; 2015():269641. PubMed ID: 26146615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
    Schima W; Függer R; Schober E; Oettl C; Wamser P; Grabenwöger F; Ryan JM; Novacek G
    AJR Am J Roentgenol; 2002 Sep; 179(3):717-24. PubMed ID: 12185052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-hold fast MR imaging--ROC analysis.
    Nishiharu T; Yamashita Y; Abe Y; Mitsuzaki K; Tsuchigame T; Nakayama Y; Takahashi M
    Radiology; 1999 Aug; 212(2):445-52. PubMed ID: 10429702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT and MR imaging of pancreatic cancer.
    Ishiguchi T; Ota T; Naganawa S; Fukatsu H; Itoh S; Ishigaki T
    Hepatogastroenterology; 2001; 48(40):923-7. PubMed ID: 11490841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined conventional magnetic resonance, magnetic resonance angiography, and magnetic resonance cholangiopancreatography in the diagnosis and staging of pancreatic carcinoma].
    Catalano C; Pavone P; Laghi A; Scipioni A; Assael F; Fanelli F; Grossi A; Passariello R
    Radiol Med; 1997 May; 93(5):556-60. PubMed ID: 9280938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer.
    Koelblinger C; Ba-Ssalamah A; Goetzinger P; Puchner S; Weber M; Sahora K; Scharitzer M; Plank C; Schima W
    Radiology; 2011 Jun; 259(3):757-66. PubMed ID: 21436084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions.
    Boraschi P; Donati F; Gigoni R; Salemi S; Faggioni L; Del Chiaro M; Boggi U; Bartolozzi C; Falaschi F
    Dig Liver Dis; 2009 Nov; 41(11):829-37. PubMed ID: 19303825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional linear endoscopic ultrasound-feasibility of a novel technique applied for the detection of vessel involvement of pancreatic masses.
    Fritscher-Ravens A; Knoefel WT; Krause C; Swain CP; Brandt L; Patel K
    Am J Gastroenterol; 2005 Jun; 100(6):1296-302. PubMed ID: 15929760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR-cholangiopancreaticography (MRCP) and MR-angiography: morphologic changes with magnetic resonance imaging.
    Vahldiek G; Broemel T; Klapdor R
    Anticancer Res; 1999; 19(4A):2451-8. PubMed ID: 10470174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice.
    Kishimoto S; Brender JR; Crooks DR; Matsumoto S; Seki T; Oshima N; Merkle H; Lin P; Reed G; Chen AP; Ardenkjaer-Larsen JH; Munasinghe J; Saito K; Yamamoto K; Choyke PL; Mitchell J; Lane AN; Fan TW; Linehan WM; Krishna MC
    Elife; 2019 Aug; 8():. PubMed ID: 31408004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based imaging of pancreatic malignancies.
    Kinney T
    Surg Clin North Am; 2010 Apr; 90(2):235-49. PubMed ID: 20362784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic ultrasound in the diagnosis of pancreatic cancer.
    Munroe CA; Fehmi SM; Savides TJ
    Expert Opin Med Diagn; 2013 Jan; 7(1):25-35. PubMed ID: 23530842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging.
    Chirindel A; Alluri KC; Chaudhry MA; Wahl RL; Pawlik TM; Herman JM; Subramaniam RM
    AJR Am J Roentgenol; 2015 May; 204(5):1093-9. PubMed ID: 25905947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging.
    Delrue L; Blanckaert P; Mertens D; Cesmeli E; Ceelen WP; Duyck P
    J Comput Assist Tomogr; 2011; 35(4):434-8. PubMed ID: 21765297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography.
    Raman SP; Horton KM; Fishman EK
    Cancer J; 2012; 18(6):511-22. PubMed ID: 23187837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of endoscopic ultrasound in the diagnosis and staging of pancreatic adenocarcinoma.
    Siddiqui AA; Tierney WM
    J Okla State Med Assoc; 2005 Nov; 98(11):539-44. PubMed ID: 16379483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of Pancreatic Cancer.
    Dimastromatteo J; Houghton JL; Lewis JS; Kelly KA
    Cancer J; 2015; 21(3):188-93. PubMed ID: 26049698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and staging of pancreatic carcinoma: MRI versus multislice-CT -- a prospective study].
    Grenacher L; Klauss M; Dukic L; Delorme S; Knaebel HP; Düx M; Kauczor HU; Büchler MW; Kauffmann GW; Richter GM
    Rofo; 2004 Nov; 176(11):1624-33. PubMed ID: 15497081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
    Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T
    Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging in the management of thoracic malignancies.
    Templeton PA; Zerhouni EA
    Radiol Clin North Am; 1989 Nov; 27(6):1099-111. PubMed ID: 2685876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.